140 related articles for article (PubMed ID: 34747535)
41. SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis.
Hulsebos TJ; Kenter S; Siebers-Renelt U; Hans V; Wesseling P; Flucke U
Am J Surg Pathol; 2014 Mar; 38(3):421-5. PubMed ID: 24525513
[TBL] [Abstract][Full Text] [Related]
42. Type 1 papillary renal cell carcinoma in a patient with schwannomatosis: Mosaic versus loss of SMARCB1 expression in respectively schwannoma and renal tumor cells.
Hulsebos TJ; Kenter S; Baas F; Nannenberg EA; Bleeker FE; van Minkelen R; van den Ouweland AM; Wesseling P; Flucke U
Genes Chromosomes Cancer; 2016 Apr; 55(4):350-4. PubMed ID: 26799435
[TBL] [Abstract][Full Text] [Related]
43. Familial schwannomatosis with a germline mutation of SMARCB1 in Japan.
Asai K; Tani S; Mineharu Y; Tsurusaki Y; Imai Y; Agawa Y; Iwaki K; Matsumoto N; Sakai N
Brain Tumor Pathol; 2015 Jul; 32(3):216-20. PubMed ID: 25631985
[TBL] [Abstract][Full Text] [Related]
44. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis.
Boyd C; Smith MJ; Kluwe L; Balogh A; Maccollin M; Plotkin SR
Clin Genet; 2008 Oct; 74(4):358-66. PubMed ID: 18647326
[TBL] [Abstract][Full Text] [Related]
45. An unusual case of schwannomatosis with bilateral maxillary sinus schwannomas and a novel SMARCB1 gene mutation.
Toms J; Harrison J; Richard H; Childers A; Reiter ER; Graham RS
J Neurosurg Spine; 2016 Jan; 24(1):160-6. PubMed ID: 26431068
[TBL] [Abstract][Full Text] [Related]
46. Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis.
Smith MJ; Bowers NL; Bulman M; Gokhale C; Wallace AJ; King AT; Lloyd SK; Rutherford SA; Hammerbeck-Ward CL; Freeman SR; Evans DG
Neurology; 2017 Jan; 88(1):87-92. PubMed ID: 27856782
[TBL] [Abstract][Full Text] [Related]
47. ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.
Evans DG; Mostaccioli S; Pang D; Fadzil O Connor M; Pittara M; Champollion N; Wolkenstein P; Thomas N; Ferner RE; Kalamarides M; Peyre M; Papi L; Legius E; Becerra JL; King A; Duff C; Stivaros S; Blanco I
Eur J Hum Genet; 2022 Jul; 30(7):812-817. PubMed ID: 35361920
[TBL] [Abstract][Full Text] [Related]
48. A deep intronic SMARCB1 variant associated with schwannomatosis.
Smith MJ; Bowers NL; Banks C; Coates-Brown R; Morris KA; Ewans L; Wilson M; Pinner J; Bhaskar SS; Cammarata-Scalisi F; Wallace AJ; Evans DGR
Clin Genet; 2020 Feb; 97(2):376-377. PubMed ID: 31502250
[No Abstract] [Full Text] [Related]
49. Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis.
Smith MJ; Kulkarni A; Rustad C; Bowers NL; Wallace AJ; Holder SE; Heiberg A; Ramsden RT; Evans DG
Am J Med Genet A; 2012 Jan; 158A(1):215-9. PubMed ID: 22105938
[TBL] [Abstract][Full Text] [Related]
50. RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas.
Melean G; Velasco A; Hernández-Imaz E; Rodríguez-Álvarez FJ; Martín Y; Valero A; Hernández-Chico C
Neurogenetics; 2012 Aug; 13(3):267-74. PubMed ID: 22752724
[TBL] [Abstract][Full Text] [Related]
51. Four distinct ipsilateral vestibular schwannomas: A case of mosaic NF2-related schwannomatosis.
Tunkel AE; Youner ER; Barseghyan H; Fu Y; Bhattacharya S; Bornhorst M; Monfared AS
Am J Clin Pathol; 2024 Mar; ():. PubMed ID: 38527168
[TBL] [Abstract][Full Text] [Related]
52. A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis.
Zhang K; Lin JW; Wang J; Wu X; Gao H; Hsieh YC; Hwu P; Liu YR; Su L; Chiou HY; Wang D; Yuan YC; Whang-Peng J; Chiu WT; Yen Y
Genet Med; 2014 Oct; 16(10):787-92. PubMed ID: 24763291
[TBL] [Abstract][Full Text] [Related]
53. Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.
Vitte J; Gao F; Coppola G; Judkins AR; Giovannini M
Nat Commun; 2017 Aug; 8(1):300. PubMed ID: 28824165
[TBL] [Abstract][Full Text] [Related]
54. Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type 2 carrying the
Basenach E; Förster A; Raab P; Alzein S; Schmidt G; Krauss JK; Schlegelberger B; Heidenreich F; Auber B; Hartmann C; Wiese B; Weber RG
Clin Neuropathol; 2022; 41(4):162-167. PubMed ID: 35445657
[TBL] [Abstract][Full Text] [Related]
55. Detection of Germline Mutations of the SMARCB1 Gene in a Chinese Family with Intraspinal Schwannomatosis.
Ding Y; Rong H; Wang Y; Liu T; Zhang J; Li S; Wang Z; Wang Y; Zhu T
World Neurosurg; 2019 Mar; 123():318-322. PubMed ID: 30576819
[TBL] [Abstract][Full Text] [Related]
56. [Features of course of pain syndrome in patients with schwannomatosis].
Makashova ES; Voloshin AG; Zolotova SV; Strelnikov VV; Golanov AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(5):48-52. PubMed ID: 38884429
[TBL] [Abstract][Full Text] [Related]
57. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
[TBL] [Abstract][Full Text] [Related]
58. Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation.
Bacci C; Sestini R; Provenzano A; Paganini I; Mancini I; Porfirio B; Vivarelli R; Genuardi M; Papi L
Neurogenetics; 2010 Feb; 11(1):73-80. PubMed ID: 19582488
[TBL] [Abstract][Full Text] [Related]
59. Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young Adults.
Pathmanaban ON; Sadler KV; Kamaly-Asl ID; King AT; Rutherford SA; Hammerbeck-Ward C; McCabe MG; Kilday JP; Beetz C; Poplawski NK; Evans DG; Smith MJ
JAMA Neurol; 2017 Sep; 74(9):1123-1129. PubMed ID: 28759666
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
